Thus, identifying the molecular mechanism of crosstalk between B7-H4 and cytotoxic CD8 T cells might open the pathway to exploring immunotherapies targeting B7-H4 in UTUC. This evidence concerns the gene VTCN1 and renal pelvis/ureter urothelial carcinoma.